Abbott Laboratories

-12.77%

More reviews (1)

Live  

Abbott Laboratories is an American multinational healthcare company that specializes in the development, manufacturing, and sale of pharmaceuticals, medical devices, and diagnostic products. It was founded in 1888 by Chicago physician Wallace Calvin Abbott and has its headquarters in Abbott Park, Illinois.
Today, Abbott Laboratories is one of the largest and most diversified healthcare companies in the world, with a presence in more than 160 countries. It is divided into four main business segments: Established Pharmaceuticals, Nutritionals, Medical Devices, and Diagnostics.
The company's pharmaceutical division focuses on developing and manufacturing prescription drugs for various therapeutic areas such as cardiovascular, neuroscience, and immunology. Its nutritional division is known for producing a wide range of nutritional products, including infant formula, adult nutrition, and diabetes care products.
Abbott Laboratories also has a significant presence in the medical device industry, producing products such as diabetes care devices, cardiovascular devices, and vision care products. Its diagnostics division offers a variety of laboratory instruments, reagents, and assays for the detection of diseases.
In addition to its core healthcare products, Abbott Laboratories also has a strong commitment to improving global health, particularly in developing countries. The company invests millions of dollars in programs and partnerships aimed at combating health issues like HIV/AIDS, malnutrition, and maternal and child health.
Overall, Abbott Laboratories has a long history of innovation and a strong commitment to improving people's lives through its products and initiatives. It continues to be a leader in the healthcare industry, constantly evolving and adapting to the changing needs of patients and healthcare providers.

Abbott Laboratories is a big company that helps people stay healthy. They make lots of different things like medicines, special food for people who need extra help, and tools that doctors use to check how healthy we are. For example, they make tests to find out if someone is sick and even machines that can help keep our hearts working well.
Abbott makes money by selling these products to hospitals, doctors, and pharmacies. When someone buys their medicine or medical equipment, Abbott gets paid for it. They also create special products for babies and other people who need help with their diets. Because they offer many different items, they can help lots of people and make money in many ways.
Abbott has been successful for a long time because they always try to invent new and better products. They also make sure their products are really good and safe, which helps doctors and patients trust them. In the future, they will likely continue to be successful because they keep researching and developing new technology to help people, especially as our world has new health challenges. People will always need help staying healthy, and because Abbott is good at providing that help, they will likely keep doing well for years to come.

MS4gTG9uZy BIaXN0b3J5 OiBBYmJvdH QgTGFib3Jh dG9yaWVzIG hhcyBiZWVu IGluIGV4aX N0ZW5jZSBm b3Igb3Zlci AxMzAgeWVh cnMsIG1ha2 luZyBpdCBv bmUgb2YgdG hlIG9sZGVz dCBhbmQgbW 9zdCBlc3Rh Ymxpc2hlZC Bjb21wYW5p ZXMgaW4gdG hlIGhlYWx0 aGNhcmUgaW 5kdXN0cnku PGJyPjIuIE 11bHRpLVNw ZWNpYWx0eS BDb21wYW55 OiBBYmJvdH QgTGFib3Jh dG9yaWVzIG 9wZXJhdGVz IGluIGEgZG l2ZXJzZSBy YW5nZSBvZi BzZWN0b3Jz IGluY2x1ZG luZyBwaGFy bWFjZXV0aW NhbHMsIG1l ZGljYWwgZG V2aWNlcywg ZGlhZ25vc3 RpY3MsIGFu ZCBudXRyaX Rpb24sIGdp dmluZyB0aG UgY29tcGFu eSBhIHdpZG UgcmVhY2gg aW4gdGhlIG hlYWx0aGNh cmUgbWFya2 V0Ljxicj4z LiBHbG9iYW wgUHJlc2Vu Y2U6IFdpdG ggb3BlcmF0 aW9ucyBpbi Btb3JlIHRo YW4gMTYwIG NvdW50cmll cywgQWJib3 R0IExhYm9y YXRvcmllcy BoYXMgYSBz dHJvbmcgZ2 xvYmFsIHBy ZXNlbmNlLC BhbGxvd2lu ZyBpdCB0by BzZXJ2ZSBh IGRpdmVyc2 UgcmFuZ2Ug b2YgY3VzdG 9tZXJzIHdv cmxkd2lkZS 48YnI+NC4g U3Ryb25nIE ZvY3VzIG9u IFJlc2Vhcm NoIGFuZCBE ZXZlbG9wbW VudDogVGhl IGNvbXBhbn kgaGFzIGEg ZGVkaWNhdG VkIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCB0ZW FtIHRoYXQg Zm9jdXNlcy BvbiBkZXZl bG9waW5nIG lubm92YXRp dmUgcHJvZH VjdHMgYW5k IHRlY2hub2 xvZ2llcyB0 byBhZGRyZX NzIHVubWV0 IG1lZGljYW wgbmVlZHMg YW5kIGltcH JvdmUgcGF0 aWVudCBvdX Rjb21lcy48 YnI+NS4gU3 Ryb25nIFBv cnRmb2xpby BvZiBQcm9k dWN0czogQW Jib3R0IExh Ym9yYXRvcm llcyBoYXMg YSBzdHJvbm cgcG9ydGZv bGlvIG9mIH Byb2R1Y3Rz LCBpbmNsdW RpbmcgcG9w dWxhciBicm FuZHMgc3Vj aCBhcyBTaW 1pbGFjLCBF bnN1cmUsIG FuZCBGcmVl c3R5bGUgTG licmUsIHdo aWNoIGFyZS B0cnVzdGVk IGJ5IGhlYW x0aGNhcmUg cHJvZmVzc2 lvbmFscyBh bmQgcGF0aW VudHMgd29y bGR3aWRlLj xicj42LiBD b21taXRtZW 50IHRvIFN1 c3RhaW5hYm lsaXR5OiBU aGUgY29tcG FueSBoYXMg YSBzdHJvbm cgY29tbWl0 bWVudCB0by BzdXN0YWlu YWJpbGl0eS BhbmQgaGFz IGltcGxlbW VudGVkIHZh cmlvdXMgaW 5pdGlhdGl2 ZXMgdG8gcm VkdWNlIGl0 cyBlbnZpcm 9ubWVudGFs IGltcGFjdC wgaW1wcm92 ZSBhY2Nlc3 MgdG8gaGVh bHRoY2FyZS wgYW5kIHN1 cHBvcnQgbG 9jYWwgY29t bXVuaXRpZX MuPGJyPjcu IEhpZ2gtUX VhbGl0eSBT dGFuZGFyZH M6IEFiYm90 dCBMYWJvcm F0b3JpZXMg aGFzIGEgcm VwdXRhdGlv biBmb3IgbW FpbnRhaW5p bmcgaGlnaC 1xdWFsaXR5 IHN0YW5kYX JkcyBpbiBp dHMgcHJvZH VjdHMgYW5k IHByb2Nlc3 NlcywgZW5z dXJpbmcgc2 FmZXR5IGFu ZCBlZmZpY2 FjeSBmb3Ig cGF0aWVudH MuPGJyPjgu IEZvY3VzIG 9uIEN1c3Rv bWVyIE5lZW RzOiBUaGUg Y29tcGFueS dzIGN1c3Rv bWVyLWNlbn RyaWMgYXBw cm9hY2ggaX MgcmVmbGVj dGVkIGluIG l0cyBjb21t aXRtZW50IH RvIG1lZXRp bmcgdGhlIG 5lZWRzIG9m IHBhdGllbn RzLCBoZWFs dGhjYXJlIH Byb2Zlc3Np b25hbHMsIG FuZCBvdGhl ciBzdGFrZW hvbGRlcnMu PGJyPjkuIF N0cm9uZyBG aW5hbmNpYW wgUGVyZm9y bWFuY2U6IE FiYm90dCBM YWJvcmF0b3 JpZXMgaGFz IGNvbnNpc3 RlbnRseSBk ZWxpdmVyZW Qgc3Ryb25n IGZpbmFuY2 lhbCBwZXJm b3JtYW5jZS wgbWFraW5n IGl0IGEgcm VsaWFibGUg YW5kIHN0YW JsZSBjb21w YW55IGZvci BpbnZlc3Rv cnMuPGJyPj EwLiBTdHJv bmcgQ29ycG 9yYXRlIEN1 bHR1cmU6IF RoZSBjb21w YW55IGhhcy BhIHN0cm9u ZyBjb3Jwb3 JhdGUgY3Vs dHVyZSB0aG F0IHZhbHVl cyBkaXZlcn NpdHksIGlu Y2x1c2lvbi wgYW5kIGVt cGxveWVlIH dlbGwtYmVp bmcsIG1ha2 luZyBpdCBh IGRlc2lyYW JsZSBwbGFj ZSB0byB3b3 JrIGZvciBl bXBsb3llZX Mu

VGhlIGNvcm UgYnVzaW5l c3MgbW9kZW wgb2YgQWJi b3R0IExhYm 9yYXRvcmll cyBpcyB0by BkZXZlbG9w LCBtYW51Zm FjdHVyZSwg YW5kIG1hcm tldCBhIGRp dmVyc2Ugcm FuZ2Ugb2Yg aGVhbHRoY2 FyZSBwcm9k dWN0cyBhbm Qgc2Vydmlj ZXMsIGluY2 x1ZGluZyBw aGFybWFjZX V0aWNhbHMs IG1lZGljYW wgZGV2aWNl cywgZGlhZ2 5vc3RpY3Ms IGFuZCBudX RyaXRpb24g cHJvZHVjdH MuIFRoZSBj b21wYW55IG 9wZXJhdGVz IGluIHNldm VyYWwgc2Vn bWVudHMsIG luY2x1ZGlu ZyBFc3RhYm xpc2hlZCBQ aGFybWFjZX V0aWNhbHMs IE1lZGljYW wgRGV2aWNl cywgTnV0cm l0aW9uLCBh bmQgRGlhZ2 5vc3RpY3Mu IDxicj5BYm JvdHQgTGFi b3JhdG9yaW VzJyBidXNp bmVzcyBzdH JhdGVneSBm b2N1c2VzIG 9uIGlubm92 YXRpb24gYW 5kIGFjcXVp c2l0aW9uIH RvIGV4cGFu ZCBpdHMgcH JvZHVjdCBw b3J0Zm9saW 8gYW5kIGVu dGVyIG5ldy BtYXJrZXRz LiBUaGUgY2 9tcGFueSBp bnZlc3RzIG hlYXZpbHkg aW4gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50IHRv IGRldmVsb3 AgbmV3IGFu ZCBpbm5vdm F0aXZlIGhl YWx0aGNhcm Ugc29sdXRp b25zLCB3aG ljaCBhcmUg dGhlbiBtYX JrZXRlZCBn bG9iYWxseS 4gQWRkaXRp b25hbGx5LC BBYmJvdHQg TGFib3JhdG 9yaWVzIGFj cXVpcmVzIG 90aGVyIGNv bXBhbmllcy B0byBkaXZl cnNpZnkgaX RzIHByb2R1 Y3Qgb2ZmZX JpbmdzIGFu ZCBleHBhbm QgaXRzIGds b2JhbCBwcm VzZW5jZS4g PGJyPlRoZS Bjb21wYW55 IGFsc28gaG FzIGEgc3Ry b25nIGZvY3 VzIG9uIGZp bmFuY2lhbC BkaXNjaXBs aW5lLCBjb3 N0IGNvbnRy b2wsIGFuZC BvcGVyYXRp b25hbCBlZm ZpY2llbmN5 IHRvIGRyaX ZlIHByb2Zp dGFiaWxpdH kgYW5kIGxv bmctdGVybS Bncm93dGgu IEl0cyBleH RlbnNpdmUg ZGlzdHJpYn V0aW9uIG5l dHdvcmsgYW 5kIHBhcnRu ZXJzaGlwcy B3aXRoIGhl YWx0aGNhcm UgcHJvdmlk ZXJzIGFuZC Bnb3Zlcm5t ZW50cyBlbm FibGUgaXQg dG8gcmVhY2 ggYSB3aWRl IGN1c3RvbW VyIGJhc2Ug YW5kIGVuc3 VyZSB0aGUg YXZhaWxhYm lsaXR5IG9m IGl0cyBwcm 9kdWN0cyBh bmQgc2Vydm ljZXMuIDxi cj5PdmVyYW xsLCBBYmJv dHQgTGFib3 JhdG9yaWVz JyBidXNpbm VzcyBtb2Rl bCBjZW50ZX JzIG9uIHBy b3ZpZGluZy BxdWFsaXR5 IGFuZCBpbm 5vdmF0aXZl IGhlYWx0aG NhcmUgc29s dXRpb25zIH doaWxlIGV4 cGFuZGluZy BpdHMgZ2xv YmFsIHJlYW NoIHRocm91 Z2ggYSBjb2 1iaW5hdGlv biBvZiBvcm dhbmljIGdy b3d0aCBhbm Qgc3RyYXRl Z2ljIGFjcX Vpc2l0aW9u cy4=

AI does pose potential challenges to Abbott Laboratories in several ways.
Firstly, substitution could occur if AI-driven innovations lead to alternative health solutions that compete with Abbott’s products. For instance, advancements in telemedicine and digital health platforms could offer consumers alternative diagnostics or health management tools that reduce reliance on traditional medical devices and tests that Abbott provides.
Secondly, disintermediation may happen as AI technologies streamline processes, connecting healthcare providers directly with patients. This shift could lessen the role of intermediaries and traditional healthcare channels that Abbott relies on for distribution and supply of its products.
Lastly, margin pressure could arise due to increased competition from tech companies entering the healthcare space. As AI lowers the costs of developing and delivering certain healthcare applications, it could compress the margins on Abbott’s products if they face pressure to reduce prices in response.
In summary, while AI can offer opportunities for innovation and efficiency, it also presents material threats to Abbott Laboratories through substitution of their products, potential disintermediation in healthcare delivery, and increased margin pressure resulting from heightened competition.

The sensitivity of Abbott Laboratories’ earnings, cash flow, and valuation to changes in interest rates can be understood through several key factors:
1. Debt Levels: If Abbott has significant outstanding debt, rising interest rates can lead to increased interest expenses. This can adversely affect net earnings and cash flow, especially if the company is unable to pass on these costs to consumers through higher prices.
2. Cost of Capital: Interest rates impact the overall cost of capital. Higher rates can lead to a higher discount rate in discounted cash flow (DCF) valuation models, which can decrease the present value of future cash flows. As a result, an increase in interest rates may lower Abbott’s valuation.
3. Consumer Spending: In a high-interest-rate environment, consumers may reduce spending on health-related products and services, which could directly impact Abbott’s sales and revenue growth. This effect can vary depending on the specific segment of Abbott’s business, such as medical devices, diagnostics, or nutrition.
4. Investment in R&D: Changes in interest rates can affect Abbott’s decisions regarding capital expenditures and investment in research and development. Higher borrowing costs might lead to more stringent capital allocation, potentially impacting long-term growth and innovation.
5. Market Sentiment: Interest rates influence overall market sentiment and investor behavior. Rising rates may lead to a shift in investment strategies, with investors potentially favoring less volatile investments (like bonds) over equities, including those of Abbott.
6. Foreign Exposure: Abbott operates globally, and changes in interest rates can also affect foreign exchange rates. If interest rates rise in the U.S., it could strengthen the dollar, making Abbott’s international sales less competitive.
Overall, Abbott Laboratories’ earnings, cash flow, and valuation are sensitive to changes in interest rates due to their impact on borrowing costs, consumer behavior, market conditions, and investment strategy.

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvMW VnWkFwdHRC bjhOcERNTE xQaHMud2Vi cCIgYWx0PS JBYmJvdHQg TGFib3JhdG 9yaWVzIiB0 aXRsZT0iQW Jib3R0IExh Ym9yYXRvcm llcyIgIGNs YXNzPSJpbW ctZmx1aWQi IGhlaWdodD 05MCB3aWR0 aD05MCBsb2 FkaW5nPSds YXp5JyBzdH lsZT0nYm9y ZGVyLXJhZG l1czogNnB4 Oyc+CgogIC AgICAgICAg ICAgICAgIC AgIDxkaXYg c3R5bGU9J2 ZsZXg6IDE7 IHRleHQtYW xpZ246IGNl bnRlcjsgbW FyZ2luLWxl ZnQ6IDVweD snPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n Zm9udC1zaX plOiAyNnB4 OyBjb2xvcj ogIzMzMzsg bWFyZ2luLW JvdHRvbTog MTVweDsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TiCBXYW50 IHRvIHJlYW QgbW9yZSBh Ym91dCBBYm JvdHQgTGFi b3JhdG9yaW VzPwogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdp bmRleC5waH A/cGFnZT1z aWdudXAnIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJh Y2tncm91bm QtY29sb3I6 ICMwMDdCRk Y7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bjb2xvcjog I2ZmZjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHBhZG Rpbmc6IDEw cHggMjBweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JvcmRlci1y YWRpdXM6ID VweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGZvbnQtd2 VpZ2h0OiBi b2xkOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbWFyZ2 luLXJpZ2h0 OiAxMHB4Ow ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdH JhbnNpdGlv bjogYmFja2 dyb3VuZC1j b2xvciAwLj NzIGVhc2U7 JwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg b25tb3VzZW 92ZXI9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA1 NmIzIicKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIG9ubW 91c2VvdXQ9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA3QkZGIi c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IGZvciBmcm VlCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxzcG FuIHN0eWxl PSdtYXJnaW 46IDAgOHB4 OyBjb2xvcj ogIzU1NTsn Pm9yPC9zcG FuPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aW5kZXgucG hwP3BhZ2U9 bG9naW4nIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGNv bG9yOiAjMD A3QkZGOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdGV4 dC1kZWNvcm F0aW9uOiB1 bmRlcmxpbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogNT AwOyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBsb2cg aW4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgoKCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxw IHN0eWxlPS dtYXJnaW4t dG9wOiAxNX B4OyBmb250 LXNpemU6ID EzcHg7IGZv bnQtd2VpZ2 h0OiBib2xk OyBjb2xvcj ogI2QzMmYy ZjsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAg8J+agC BEb27igJl0 IG1pc3MgPG k+IlRoZSBD aGVja2xpc3 QgVmFsdWUg SW52ZXN0b3 Ig4oCUIEEg U21hcnRlci BXYXkgdG8g UGljayBTdG 9ja3MiPC9p PiDigJQgZn JlZSEKICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9wPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx MnB4OyBmb2 50LXNpemU6 IDEzcHg7IG NvbG9yOiAj NDQ0Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIG5v dyBhbmQgZ2 V0IG91ciBm cmVlIGVCb2 9rIAogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGI+VGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2Nrczwv Yj4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIC0t PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8IS0t CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxkaXYg c3R5bGU9J2 1hcmdpbi10 b3A6IDE2cH g7IGZvbnQt c2l6ZTogMT RweDsgY29s b3I6ICM0ND Q7IGZvbnQt ZmFtaWx5Oi AtYXBwbGUt c3lzdGVtLC BCbGlua01h Y1N5c3RlbU ZvbnQsIFNl Z29lIFVJLC BSb2JvdG8s IEhlbHZldG ljYSBOZXVl LCBzYW5zLX NlcmlmOyBs aW5lLWhlaW dodDogMS42 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBIYXZlIH lvdSBoZWFy ZCBhYm91dC BvdXIgc2hv cnQgPHN0cm 9uZyBzdHls ZT0nZm9udC 13ZWlnaHQ6 IDYwMDsnPk RhaWx5IFZp ZGVvIE5ld3 NsZXR0ZXI8 L3N0cm9uZz 4/CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdodHRwcz ovL3d3dy5p bnNpZ2h0Zn VsdmFsdWUu Y29tL25ld3 NsZXR0ZXIu cGhwJyB0YX JnZXQ9J19i bGFuaycgc3 R5bGU9J2Nv bG9yOiAjMD A3QkZGOyB0 ZXh0LWRlY2 9yYXRpb246 IG5vbmU7IG ZvbnQtd2Vp Z2h0OiA1MD A7IG1hcmdp bi1sZWZ0Oi A2cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBGaW5kIG 91dCBtb3Jl CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 L2E+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICAgICAgIC AgICAgICAt LT4KICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgCiAgICAg ICAgCiAgIC AgICAgPHNw YW4gY2xhc3 M9J2JsdXJy ZWQtdGV4dC c+CiAgICAg ICAgICAgIE 1TNGdRV0pp YjMgUjBJRX hoWW05eSBZ WFJ2Y21sbG N5IEIzWVhN Z1ptOTEgYm 1SbFpDQnBi aSBBeE9EZz RJR0o1IElF UnlMaUJYWV cgeHNZV05s SUVNdSBJRU ZpWW05MGRD IHdnZDJodk lIZGggY3lC aElFTm9hVy BOaFoyOGdj R2g1IGMybG phV0Z1SUcg RnVaQ0J3YU dGeSBiV0Zq YVhOMExpIE JKYm1sMGFX RnMgYkhrc0 lIUm9aUyBC amIyMXdZVz U1IElIZGhj eUJtYjIgTj FjMlZrSUc5 dSBJRzFoYm 5WbVlXIE4w ZFhKcGJtY2 cgWkhKMVoz TWdZVyA1a0 lIQnliMlIx IFkybHVaeU JpYjMgUmhi bWxqWVd3Zy BaWGgwY21G amRIIE1zSU dKMWRDQnAg ZENCc1lYUm xjaSBCbGVI QmhibVJsIF pDQnBiblJ2 SUcgSnNiMj lrSUdkcyBk V052YzJVZ2 JXIDl1YVhS dmNtbHUgWn l3Z2JuVjBj bSBsMGFXOX VJSEJ5IGIy UjFZM1J6TE MgQnRaV1Jw WTJGcyBJR1 JsZG1salpY IE1zSUdGdV pDQmsgYVdG bmJtOXpkRy BsamN5NDhZ bkkrIE1pNG dWR2hsSUcg TnZiWEJoYm 5uaSBnSmx6 SUdacGNuIE 4wSUcxaGFt OXkgSUdKeV pXRnJkRyBo eWIzVm5hQ0 JqIFlXMWxJ R2x1SUQgRT RPVE1zSUhk byBaVzRnYV hRZ1pHIFYy Wld4dmNHVm sgSUdFZ2JX VmthVyBOcG JtVWdZMkZz IGJHVmtJSF JvWlMgQkJZ bUp2ZEhRZy BRV3hyWVd4 dmFXIFJoYk NCRGIyMXcg WVc1NTRvQ1 pjeSBCTlpX UnBZMmx1IF lXd2dSR2xu WlggTjBhWF psSUVWcyBh WGhwY2k0Z1 ZHIGhwY3lC dFpXUnAgWT JsdVpTQmla VyBOaGJXVW dkMmxrIFpX eDVJSEJ2Y0 ggVnNZWEln Wm05eSBJSE psYkdsbGRt IGx1WnlCd1 lXbHUgSUdG dVpDQnBiWC BCeWIzWnBi bWNnIFpHbG 5aWE4wYVcg OXVMQ0JoYm 1RZyBhWFFn YUdWc2NHIF ZrSUhCMWRD QkIgWW1Kdm RIUWdURyBG aWIzSmhkRz l5IGFXVnpJ Rzl1SUggUm 9aU0J0WVhB dSBQR0p5UG pNdUlFIGx1 SURFNU1ETX MgSUVGaVlt OTBkQyBCTV lXSnZjbUYw IGIzSnBaWE 1nWW0gVmpZ VzFsSUc5dS BaU0J2WmlC MGFHIFVnWm 1seWMzUWcg WTI5dGNHRn VhVyBWeklI UnZJSEJ5IG IyUjFZMlVn WVMgQnpkR0 Z1WkdGeSBa R2w2WldRZ1 ptIDl5YlNC dlppQmsgYV dkcGRHRnNh WCBNc0lHRW dhR1ZoIGNu UWdiV1ZrYV cgTmhkR2x2 Ymk0ZyBWR2 hwY3lCb1pX IHh3WldRZ2 NtVjIgYjJ4 MWRHbHZibS BsNlpTQjBh R1VnIGRISm xZWFJ0Wlcg NTBJRzltSU dobCBZWEow SUdScGMyIF ZoYzJVdVBH SnkgUGpRdU lFUjFjbSBs dVp5QlhiM0 pzIFpDQlhZ WElnU1Uga3 NJRUZpWW05 MCBkQ0JNWV dKdmNtIEYw YjNKcFpYTW cgY0hKdlpI VmpaVyBRZ1 lXNGdaWGh3 IFpYSnBiV1 Z1ZEcgRnNJ R1J5ZFdjcy BJSEJsYm1s amFXIHhzYV c0c0lHbHUg SUd4aGNtZG xJSCBGMVlX NTBhWFJwIF pYTXVJRlJv YVggTWdkMk Z6SUhWeiBa V1FnZEc4Z2 RIIEpsWVhR Z2QyOTEgYm 1SbFpDQnpi MiB4a2FXVn ljeUJ2IGJp QjBhR1VnWm 4gSnZiblFn YkdsdSBaWE 1zSUdobGJI IEJwYm1jZ2 RHOGcgYzJG MlpTQnRZVy A1NUlHeHBk bVZ6IExqeG ljajQxTGkg QkJZbUp2ZE hRZyBUR0Zp YjNKaGRHID l5YVdWeklH aGggY3lCaE lHeHZibSBj Z2FHbHpkRz l5IGVTQnZa aUJrWlggWm xiRzl3YVc1 biBJR2x1Ym 05MllYIFJw ZG1VZ2JXVm sgYVdOaGJD QmtaWCBacF kyVnpMaUJK IGJpQXhPVF UwTEMgQjBh R1VnWTI5dC BjR0Z1ZVNC cGJuIFJ5Yj JSMVkyVmsg SUhSb1pTQm 1hWCBKemRD QnRZWE56IE xYQnliMlIx WTIgVmtJR0 pzYjI5ayBJ R2RzZFdOdm MyIFVnYldW MFpYSXMgSU hkb2FXTm9J SCBKbGRtOX NkWFJwIGIy NXBlbVZrSU cgUnBZV0ps ZEdWeiBJRz FoYm1GblpX IDFsYm5RdV BHSnkgUGpZ dUlFbHVJRC BJd01URXNJ RUZpIFltOT BkQ0JNWVcg SnZjbUYwYj NKcCBaWE1n YzNCc2FYIF FnYVc1MGJ5 QjAgZDI4Z2 MyVndZWCBK aGRHVWdZMj l0IGNHRnVh V1Z6T2kgQk JZbUp2ZEhR cyBJSGRvYV dOb0lHIFp2 WTNWelpYTW cgYjI0Z2JX VmthVyBOaG JDQmtaWFpw IFkyVnpMQ0 JrYVcgRm5i bTl6ZEdsai BjeXdnWVc1 a0lHIDUxZE hKcGRHbHYg YmlCd2NtOW tkVyBOMGN5 d2dZVzVrIE lFRmlZbFpw WlMgd2dkMm hwWTJnZyBa bTlqZFhObG N5IEJ2YmlC d2FHRnkgYl dGalpYVjBh VyBOaGJITX VQR0p5IFBq Y3VJRUZpWW 0gOTBkQ0JN WVdKdiBjbU YwYjNKcFpY IE1nYUdGek lHMWggWkdV Z2MyVjJaWC BKaGJDQnVi M1JoIFlteG xJR0ZqY1gg VnBjMmwwYV c5dSBjeUJ2 ZG1WeUlIIF JvWlNCNVpX RnkgY3l3Z2 FXNWpiSCBW a2FXNW5JSF JvIFpTQndh R0Z5YlcgRm paWFYwYVdO aCBiQ0JqYj Ixd1lXIDU1 SUVGc2VtRW cgUTI5eWNH OXlZWCBScG IyNGdhVzRn IE1qQXdNU0 JoYm0gUWdk R2hsSUc1MS BkSEpwZEds dmJpIEJqYj Ixd1lXNTUg SUU1bGMzUn NaZSBLQW1Y TWdhVzVtIF lXNTBJRzUx ZEggSnBkR2 x2YmlCayBh WFpwYzJsdm JpIEJwYmlB eU1ERTMgTG p4aWNqNDRM aSBCVWFHVW dZMjl0IGNH RnVlU0JvWV ggTWdZU0J6 ZEhKdiBibW NnWjJ4dllt IEZzSUhCeV pYTmwgYm1O bExDQjNhWC BSb0lHOXda WEpoIGRHbH Zibk1nYVcg NGdiM1psY2 lBeCBOakFn WTI5MWJuIF J5YVdWeklH RnUgWkNCd2 NtOWtkVyBO MGN5QnpiMn hrIElHbHVJ RzF2Y20gVW dkR2hoYmlB eCBOakF1UE dKeVBqIGt1 SUVsdUlESX cgTVRZc0lF RmlZbSA5MG RDQk1ZV0p2 IGNtRjBiM0 pwWlggTWdi V0ZrWlNCaC BJRzFoYW05 eUlHIEp5Wl dGcmRHaHkg YjNWbmFDQn BiaSBCMGFH VWdabWxsIG JHUWdiMlln WkcgbGhaMj V2YzNScCBZ M01nZDJsMG FDIEIwYUdV Z1pHVjIgWl d4dmNHMWxi biBRZ2IyWW dZU0J5IFlY QnBaQ0IwWl ggTjBJR1p2 Y2lCMCBhR1 VnV21scllT IEIyYVhKMW N5NGcgVkdo cGN5QjBaWC BOMElHTnZk V3hrIElIQn liM1pwWkcg VWdjbVZ6ZF d4MCBjeUJw YmlCcWRYIE 4wSUdacGRt VWcgZEc4Z2 MyVjJaVyA0 Z1pHRjVjeX dnIFkyOXRj R0Z5WlcgUW dkRzhnZDJW bCBhM01nZD JsMGFDIEIw Y21Ga2FYUn AgYjI1aGJD QjBaWCBOMG FXNW5JRzFs IGRHaHZaSE 11UEcgSnlQ akV3TGlCQi BZbUp2ZEhR Z1RHIEZpYj NKaGRHOXkg YVdWeklHbH pJRyBOdmJX MXBkSFJsIF pDQjBieUJ6 ZFggTjBZV2 x1WVdKcCBi R2wwZVNCaG JtIFFnYUdG eklITmwgZE NCbmIyRnNj eSBCMGJ5Qn laV1IxIFky VWdhWFJ6SU cgTmhjbUp2 YmlCbSBiMj kwY0hKcGJu IFFzSUdsdV kzSmwgWVhO bElHVnVaWC BKbmVTQmxa bVpwIFkybG xibU41TEMg QmhibVFnWk dWaiBjbVZo YzJVZ2QyIE YwWlhJZ2RY TmggWjJVdU lGUm9aUyBC amIyMXdZVz U1IElHaGhj eUJoYkggTn ZJR2x0Y0d4 bCBiV1Z1ZE dWa0lIIEps WTNsamJHbH UgWnlCd2Nt OW5jbSBGdG N5QmhibVFn IGFYTWdZMj l1ZEcgbHVk VzkxYzJ4NS BJSGR2Y210 cGJtIGNnZE c4Z2NtVmsg ZFdObElIZG hjMyBSbElH bHVJR2wwIG N5QnZjR1Z5 WVggUnBiMj V6TGc9PQog ICAgICAgID wvc3Bhbj4K ICAgICAgIC AKICAgICAg ICA=